Michael JD’s Email & Phone

Image of Michael JD

Michael JD

Vice President, Regulatory Affairs @ Surface Oncology Inc.

Michael JD Contact Details

Cambridge, Massachusetts
Vice President, Regulatory Affairs @ Surface Oncology Inc.
Industry Representative, FDA Pharmacy Compounding Advisory Committee (CDER) @ FDA
Adjunct Faculty, Regulatory Affairs and Health Policy Program @ Massachusetts College of Pharmacy and Health Sciences
Juris Doctor, Certificate in Intellectual Property & Technology @ University at Buffalo School of Law

Seasoned global regulatory strategist with strong medical, legal and regulatory, and public health credentials, leadership and project management skils, and diverse experience in the biopharmaceutical industry and academia EXPERTISE AND SPECIALTY INTERESTS: US and EU pharmaceutical law & regulation, 505(b)(1) and (b)(2), 351(k) pathway for biosimilars; innovative drug development; oncology, ophthalmology, gastroenterology, stem cells, cardiology, and multiple 

Looking for a different Michael JD?

Get an email address for anyone on LinkedIn with the ContactOut Chrome extension
Install the extension - it's free!

ContactOut is used by recruiters at 76% of the Fortune 500 companies

Similar Profiles to Michael JD

Recruiters looking for Michael JD also viewed
Most popular profiles
Related profiles
  • No profiles to display.

Looking for colleagues of Chris Shelby at Company Inc?

Image of Jonathan Jonathan Hill
Director of Immunology
Image of J. J. SHRM-CP
Human Resources Manager
Image of Karen Karen D'Amour
Senior Medical Writer
Image of Vito Vito Palombella
Chief Scientific Officer
Image of Geoffrey Geoffrey McDonough
Independent Director
Image of Sonia Sonia Ph.D
Scientist, Pharmacology
Image of Benjamin Benjamin Lee
Executive Director, Translational Science
Image of David David Konciak
Vice President, Business Development & Strategy
Image of Laura Laura DiMarzio
Senior Director, Regulatory Affairs and Quality Assurance
Image of Christina Christina Riordan
Company Name Surface Oncology Inc.